| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |